Dilution of equity value resulting from the exercise of stock acquisition rights
First written in FY2016. 14 of 25 entries say "Materialised", first in FY2017-Q3. Latest entry: FY2026.
Globalway moved to the "Worse" side of this theme in 2017, 4 years before the typical company in this theme (2021).
The whole theme swung hardest in 2017: 28 of 54 companies on the "Worse" side.
32 other companies' latest entry also says "Worsened".
- FY2026WorsenedAnnual report
「Class, details and number of shares underlying stock acquisition rights (shares) * 2,600,000 (Note) 2」
There were 2,600,000 unexercised shares underlying Series 17 stock acquisition rights, and 134,800 shares were issued through the exercise of stock acquisition rights during the fiscal year. A further 1,000,000 shares were issued by the filing date, increasing exposure from potential and issued shares. - FY2026-H1WorsenedAnnual report
「Number of shares underlying stock acquisition rights (shares) * 2,700,000 (Note) 2」
Series 17 stock acquisition rights created 2,700,000 potential shares, and 100,000 shares were delivered during the interim period through the exercise of 1,000 stock acquisition rights. Dilution exposure increased further. - FY2024-Q2WorsenedAnnual report
「Series 16 Stock Acquisition Rights Resolution under Article 370 of the Companies Act, 20 July 2023 Number of stock acquisition rights (units) 567,450 (Note) 1 Number of shares underlying the stock acquisition rights (shares) 567,450 (Note) 1」
The company issued 567,450 Series 16 stock acquisition rights, creating the same number of potential shares. The exercise period is from 7 August 2023 to 6 August 2033. - FY2023MitigatedAnnual report
「Number of shares underlying stock acquisition rights (shares) 50,250」
The number of shares underlying Series 14 stock acquisition rights declined from 52,500 at the end of the previous consolidated fiscal year to 50,250. However, the potential for dilution from potential shares remains. - FY2023-Q1MaterialisedAnnual report
「1 April 2022–30 June 2022 (Note) 750 36,403,200 20 50,041 20 424,148 (Note) Increase due to the exercise of stock acquisition rights.」
750 shares were issued through the exercise of stock acquisition rights during the first quarter, increasing the number of shares issued, share capital and capital surplus. - FY2022MitigatedAnnual report
「As of the end of the consolidated fiscal year, the number of potential shares from stock acquisition rights was 110,850, equivalent to 1.70% of the total 36,402,450 shares issued.」
Although share issuance through the exercise of stock acquisition rights progressed during the fiscal year, the potential share ratio declined from 3.1% in the previous fiscal year to 1.70%. - FY2022-Q3MaterialisedAnnual report
「During the third quarter accounting period, stock acquisition rights attached to bonds with stock acquisition rights subject to adjustment clauses in the exercise price were exercised as follows.」
1,550 Series 15 stock acquisition rights were exercised, resulting in 930,000 shares delivered and proceeds of ¥477,865,000. Share issuance and dilution through the exercise of stock acquisition rights proceeded in practice. - FY2022-Q2MaterialisedAnnual report
「1 July 2021–16 September 2021 (Note) 1 1,147 1,167,739 1,157 91,999 1,157 168,600 18 September 2021–30 September 2021 (Note) 1 8,610 5,847,305 1,431 93,431 1,431 170,031 (Note) 1. Increase due to the exercise of stock acquisition rights.」
A total of 9,757 shares were issued through the exercise of stock acquisition rights during the second-quarter accounting period. The filing also states that 155,000 shares were issued through the exercise of Series 15 stock acquisition rights by the filing date. - FY2022-Q1MaterialisedAnnual report
「1 April 2021–30 June 2021 (Note) 100 1,166,592 51 90,842 51 167,442 (Note) Increase due to the exercise of stock acquisition rights.」
100 shares were issued through the exercise of stock acquisition rights during the first quarter, increasing the number of shares issued, share capital and capital surplus. - FY2021WorsenedAnnual report
「As of the end of the consolidated fiscal year, the number of potential shares from stock acquisition rights was 36,643, equivalent to 3.1% of the total 1,166,492 shares issued.」
The potential share ratio rose from 2.4% in the previous fiscal year to 3.1%, increasing dilution exposure. A further 200 shares were issued through the exercise of stock acquisition rights during the fiscal year. - FY2021-Q3WorsenedAnnual report
「株式会社グローバルウェイ Series 14 Stock Acquisition Rights Number of stock acquisition rights (units) * 15,850 units Number of shares underlying the stock acquisition rights (shares) * Common shares 15,850 shares Exercise period of stock acquisition rights * 19 November 2020 to 18 November 2030」
The company issued 15,850 Series 14 stock acquisition rights, creating additional potential dilution exposure. A further 200 shares were issued through the exercise of stock acquisition rights during the third-quarter accounting period. - FY2020MaterialisedAnnual report
「As of the end of the consolidated fiscal year, the number of potential shares from stock acquisition rights was 27,863, equivalent to 2.4% of the total 1,166,292 shares issued.」
A further 2,450 shares were issued through the exercise of stock acquisition rights during the consolidated fiscal year. The potential share ratio was 2.4%, leaving dilution exposure. - FY2020-Q3MaterialisedAnnual report
「Common shares 1,166,002 1,166,292 Tokyo Stock Exchange (Mothers)」
The number of shares issued was 1,166,002 at the end of the third-quarter accounting period and 1,166,292 as of the filing date, indicating that share issuance through the exercise of stock acquisition rights continued. - FY2020-Q2MaterialisedAnnual report
「1 July 2019– 30 September 2019 850 1,166,002 220 90,617 220 167,217 (Note) Increase due to the exercise of stock acquisition rights.」
850 shares were issued through the exercise of stock acquisition rights during the second-quarter accounting period, increasing the number of shares issued, share capital and capital surplus. - FY2020-Q1MaterialisedAnnual report
「The increase resulted from the exercise of share acquisition rights.」
1,310 shares were issued through the exercise of stock acquisition rights during the first quarter, followed by a further 250 shares in July 2019. - FY2019-Q3MaterialisedAnnual report
「1 October 2018–31 December 2018 110 1,163,842 51 214,811 51 166,651 (Note) Increase due to the exercise of stock acquisition rights.」
110 shares were issued through the exercise of stock acquisition rights during the third-quarter accounting period, increasing the number of shares issued, share capital and capital surplus. - FY2019-Q2MaterialisedAnnual report
「The increase resulted from the exercise of share acquisition rights.」
From July through September 2018, 779 shares were issued through the exercise of stock acquisition rights, and share issuance resulting in dilution continued. - FY2019-Q1MaterialisedAnnual report
「The increase resulted from the exercise of share acquisition rights.」
3,396 shares were issued through the exercise of stock acquisition rights during the first quarter, followed by a further 577 shares in July. - FY2018WorsenedAnnual report
「As of the end of the fiscal year, the number of potential shares from stock acquisition rights was 53,735, equivalent to 4.6% of the total 1,159,557 shares issued.」
The potential share ratio rose from 2.0% in the previous fiscal year to 4.6%, increasing dilution exposure. - FY2018-Q3MaterialisedAnnual report
「(Note) Increase due to exercise of stock acquisition rights.」
The company states that 25 shares were issued through the exercise of stock acquisition rights during the third-quarter accounting period, followed by a further 197 shares in January 2018. - FY2018-Q2MaterialisedAnnual report
「(Note) Increase due to exercise of stock acquisition rights.」
From July through September 2017, 290 shares were issued through the exercise of stock acquisition rights, increasing the total shares issued, share capital and capital surplus. - FY2018-Q1WorsenedAnnual report
「Number of stock acquisition rights (units) 40,000」
The company issued 40,000 stock acquisition rights during the first-quarter accounting period, increasing potential dilution exposure. - FY2017MitigatedAnnual report
「As of the end of the fiscal year, the number of potential shares from stock acquisition rights was 23,250, equivalent to 2.0% of the total 1,156,350 shares issued.」
Although shares continued to be issued through the exercise of stock acquisition rights, the potential share ratio declined from 2.8% in the previous disclosure to 2.0%. - FY2017-Q3MaterialisedAnnual report
「The increase resulted from the exercise of share acquisition rights.」
160 shares were issued through the exercise of stock acquisition rights during the third-quarter accounting period, meaning that potential shares were actually issued. - FY2016First statedAnnual report
「As of the end of the fiscal year, the number of potential shares from stock acquisition rights was 29,470, equivalent to 2.8% of the total 1,034,560 shares issued.」
The company discloses the potential dilution of per-share value from the exercise of stock acquisition rights, together with the potential share ratio.